4.6 Article

Short-Term Ex Vivo Culture of CTCs from Advance Breast Cancer Patients: Clinical Implications

Journal

CANCERS
Volume 13, Issue 11, Pages -

Publisher

MDPI
DOI: 10.3390/cancers13112668

Keywords

CTC; cell culture; liquid biopsy; breast cancer

Categories

Funding

  1. Roche-Chus Joint Unit - Axencia Galega de Innovacion (GAIN), Conselleria de Economia, Emprego e Industria [IN853B 2018/03]
  2. Axudas Predoutorais do IDIS (Instituto de Investigacion Sanitaria de Santiago)
  3. Instituto de Salud Carlos III (ISCiii) [FI19/00140]
  4. European Regional Development Fund (FEDER)

Ask authors/readers for more resources

In this study, circulating tumor cells (CTCs) were cultured in vitro using growth factors and Nanoemulsions. The cultured CTCs showed mesenchymal and stem cell characteristics, and their culture duration was predictive of progression-free survival in breast cancer patients. The subset of CTCs capable of ex vivo growth may represent the population with metastatic potential in vivo.
Simple Summary Circulating tumor cells (CTCs) are responsible for metastasis, they represent tumor biology and have also predictive value for therapy monitoring and prognosis of metastatic breast cancer patients. In the blood, CTCs are found in low frequency and a small percentage of them survive. Therefore, achieving their expansion in vitro will allow performing characterization and functional analysis. In this work, we used growth factors and Nanoemulsions to support CTCs culture. We have seen that the CTCs subpopulation capable of ex vivo expanding presented mesenchymal and stem characteristics and loss of epithelial markers. Besides, CTC culture predicted progression-free survival. Background: Circulating tumor cells (CTC) have relevance as prognostic markers in breast cancer. However, the functional properties of CTCs or their molecular characterization have not been well-studied. Experimental models indicate that only a few cells can survive in the circulation and eventually metastasize. Thus, it is essential to identify these surviving cells capable of forming such metastases. Methods: We isolated viable CTCs from 50 peripheral blood samples obtained from 35 patients with advanced metastatic breast cancer using RosetteSep(TM) for ex vivo culture. The CTCs were seeded and monitored on plates under low adherence conditions and with media supplemented with growth factors and Nanoemulsions. Phenotypic analysis was performed by immunofluorescence and gene expression analysis using RT-PCR and CTCs counting by the Cellsearch(R) system. Results: We found that in 75% of samples the CTC cultures lasted more than 23 days, predicting a shorter Progression-Free Survival in these patients, independently of having >= 5 CTC by Cellsearch(R). We also observed that CTCs before and after culture showed a different gene expression profile. Conclusions: the cultivability of CTCs is a predictive factor. Furthermore, the subset of cells capable of growing ex vivo show stem or mesenchymal features and may represent the CTC population with metastatic potential in vivo.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available